Combined 18F-FDG-PET/CT Imaging in Radiotherapy Target Delineation for Head-and-Neck Cancer
- 1 March 2009
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 73 (3) , 759-763
- https://doi.org/10.1016/j.ijrobp.2008.04.059
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Role of fusion in radiotherapy treatment planningSeminars in Nuclear Medicine, 2003
- Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell CarcinomaJournal of Clinical Oncology, 2002
- Positron Emission Tomography Scanning: Current and Future ApplicationsAnnual Review of Medicine, 2002
- FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinomaHead & Neck, 2002
- Mediastinal Lymph Node Sampling Following Positron Emission Tomography With Fluorodeoxyglucose Imaging in Lung Cancer StagingChest, 2001
- Combined PET/CT Imaging in Oncology Impact on Patient ManagementClinical Positron Imaging, 2000
- Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformalityInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999
- Invasives Zervixkarzinom (pT2b-pT4a)Der Radiologe, 1997
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995